STTR Phase I: Wireless Sensing of Body Movement: Detection and Evaluation of Lameness in Horses

Award Information
Agency:
National Science Foundation
Amount:
$149,912.00
Program:
STTR
Contract:
0809450
Solitcitation Year:
N/A
Solicitation Number:
NSF 07-586
Branch:
N/A
Award Year:
2008
Phase:
Phase I
Agency Tracking Number:
0809450
Solicitation Topic Code:
EO
Small Business Information
Equinosis LLC
2404 Cimarron Drive, Columbia, MO, 65203
Hubzone Owned:
N
Woman Owned:
N
Socially and Economically Disadvantaged:
N
Duns:
800123254
Principal Investigator
 Allyn G Mann
 NoDeg
 (573) 268-5253
 allynmann@everestkc.net
Business Contact
 Allyn G Mann
Title: NoDeg
Phone: (573) 268-5253
Email: allynmann@everestkc.net
Research Institution
 University of Missouri - Columbia
 Michael Nichols
 2404 Cimarron Dr
340A Bond Life Sciences Center
Columbia, MO, 65203
 (573) 882-6726
 Nonprofit college or university
Abstract
This Small Business Technology Transfer Phase I project focuses on lameness which is one of the most common health problems for horses. Treatment is most effective in the earliest stages of lameness, however the subjective diagnostic methods currently used by large animal are imprecise and inaccurate. To improve the quality of lameness evaluation, the startup company Equinosis is leversaging research at the University of Missouri to develop a field-ready, portable, wireless body-sensor-based system that can diagnose the affected limb and severity of lameness in horses sooner and more effectively than current methods. This computer-driven technology determines the degree of lameness by measuring the head and pelvic movements of horses. In the proposed project, Equinosis will evaluate the patterns of head and pelvic motions of horses with definite diagnoses of naturally-occurring and experimentally-induced (temporary) lameness. The objective of this work will be to verify both the technology and University of Missouri research data. The broader impacts of this research may extend beyond the initial goals of improved diagnosis and earlier, more effective treatment of lameness in horses. While Equinosis has identified lameness in horses as its initial commercialization target, the company believes that this patent-pending technology can be extended to detect other ailments in other animal species. Further development of the technology could eventually assist in the diagnosis of medical issues for humans, especially in those cases where the patient has referred pain or cannot communicate symptoms clearly to medical professionals.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government